• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-16调节乳腺癌细胞中HuR对细胞周期蛋白E1的调控。

MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cells.

作者信息

Guo Xun, Connick Melanie C, Vanderhoof Jennifer, Ishak Mohammad-Ali, Hartley Rebecca S

机构信息

Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.

出版信息

Int J Mol Sci. 2015 Mar 30;16(4):7112-32. doi: 10.3390/ijms16047112.

DOI:10.3390/ijms16047112
PMID:25830480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4425007/
Abstract

RNA binding protein (RBPs) and microRNAs (miRNAs or miRs) are post-transcriptional regulators of gene expression that are implicated in development of cancers. Although their individual roles have been studied, the crosstalk between RBPs and miRNAs is under intense investigation. Here, we show that in breast cancer cells, cyclin E1 upregulation by the RBP HuR is through specific binding to regions in the cyclin E1 mRNA 3' untranslated region (3'UTR) containing U-rich elements. Similarly, miR-16 represses cyclin E1, dependent on its cognate binding sites in the cyclin E1 3'UTR. Evidence in the literature indicates that HuR can regulate miRNA expression and recruit or dissociate RNA-induced silencing complexes (RISC). Despite this, miR-16 and HuR do not affect the other's expression level or binding to the cyclin E1 3'UTR. While HuR overexpression partially blocks miR-16 repression of a reporter mRNA containing the cyclin E1 3'UTR, it does not block miR-16 repression of endogenous cyclin E1 mRNA. In contrast, miR-16 blocks HuR-mediated upregulation of cyclin E1. Overall our results suggest that miR-16 can override HuR upregulation of cyclin E1 without affecting HuR expression or association with the cyclin E1 mRNA.

摘要

RNA结合蛋白(RBPs)和微小RNA(miRNAs或miRs)是基因表达的转录后调节因子,与癌症的发生发展有关。尽管它们各自的作用已得到研究,但RBPs与miRNAs之间的相互作用仍在深入研究中。在此,我们表明,在乳腺癌细胞中,RBP HuR通过特异性结合细胞周期蛋白E1信使核糖核酸(mRNA)3'非翻译区(3'UTR)中富含U元件的区域来上调细胞周期蛋白E1。同样,miR-16依赖于其在细胞周期蛋白E1 3'UTR中的同源结合位点来抑制细胞周期蛋白E1。文献证据表明,HuR可以调节miRNA表达,并招募或解离RNA诱导沉默复合体(RISC)。尽管如此,miR-16和HuR并不影响彼此的表达水平或与细胞周期蛋白E1 3'UTR的结合。虽然HuR过表达部分阻断了miR-16对含有细胞周期蛋白E1 3'UTR的报告mRNA的抑制作用,但它并不阻断miR-16对内源性细胞周期蛋白E1 mRNA的抑制作用。相反,miR-16阻断了HuR介导的细胞周期蛋白E1上调。总体而言,我们的结果表明,miR-16可以在不影响HuR表达或与细胞周期蛋白E1 mRNA结合的情况下,推翻HuR对细胞周期蛋白E1的上调作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/4425007/56b4b91057cc/ijms-16-07112-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/4425007/aa5d61bed272/ijms-16-07112-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/4425007/56b4b91057cc/ijms-16-07112-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/4425007/aa5d61bed272/ijms-16-07112-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e9/4425007/56b4b91057cc/ijms-16-07112-g002a.jpg

相似文献

1
MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cells.微小RNA-16调节乳腺癌细胞中HuR对细胞周期蛋白E1的调控。
Int J Mol Sci. 2015 Mar 30;16(4):7112-32. doi: 10.3390/ijms16047112.
2
HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.HuR在MCF-7乳腺癌细胞中导致细胞周期蛋白E1失调。
Cancer Res. 2006 Aug 15;66(16):7948-56. doi: 10.1158/0008-5472.CAN-05-4362.
3
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.孕激素介导的致癌信号下调肿瘤抑制 miR-16 促进乳腺癌发生。
Breast Cancer Res. 2012 May 14;14(3):R77. doi: 10.1186/bcr3187.
4
Interplay between RNA-binding protein HuR and microRNA-125b regulates p53 mRNA translation in response to genotoxic stress.RNA结合蛋白HuR与微小RNA-125b之间的相互作用调节p53 mRNA翻译以响应基因毒性应激。
RNA Biol. 2016 Nov;13(11):1152-1165. doi: 10.1080/15476286.2016.1229734. Epub 2016 Sep 3.
5
RNA-binding protein HuR and the members of the miR-200 family play an unconventional role in the regulation of c-Jun mRNA.RNA结合蛋白HuR和miR-200家族成员在c-Jun mRNA的调控中发挥着非传统作用。
RNA. 2016 Oct;22(10):1510-21. doi: 10.1261/rna.057588.116. Epub 2016 Jul 29.
6
Cold-inducible RNA-binding protein contributes to human antigen R and cyclin E1 deregulation in breast cancer.冷诱导 RNA 结合蛋白促进乳腺癌中人类抗原 R 和细胞周期蛋白 E1 的失调。
Mol Carcinog. 2010 Feb;49(2):130-40. doi: 10.1002/mc.20582.
7
HuR facilitates miR-93-5p-induced activation of MAP3K2 translation via MAP3K2 3'UTR ARE2 in hepatocellular carcinoma.HuR 通过肝癌细胞中 MAP3K2 3'UTR ARE2 促进 miR-93-5p 诱导的 MAP3K2 翻译。
Biochem Biophys Res Commun. 2024 Aug 30;722:150152. doi: 10.1016/j.bbrc.2024.150152. Epub 2024 May 21.
8
MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.miR-137 靶向雌激素相关受体α,从而损害乳腺癌细胞的增殖和迁移能力。
PLoS One. 2012;7(6):e39102. doi: 10.1371/journal.pone.0039102. Epub 2012 Jun 18.
9
RNA-binding proteins La and HuR cooperatively modulate translation repression of PDCD4 mRNA.RNA 结合蛋白 La 和 HuR 协同调节 PDCD4 mRNA 的翻译抑制。
J Biol Chem. 2021 Jan-Jun;296:100154. doi: 10.1074/jbc.RA120.014894. Epub 2020 Dec 9.
10
Synergistic regulation of mRNA by HuR and miR-26/RISC in neurons.HuR 和 miR-26/RISC 在神经元中对 mRNA 的协同调控。
RNA Biol. 2021 Jul;18(7):988-998. doi: 10.1080/15476286.2020.1795409. Epub 2020 Aug 11.

引用本文的文献

1
Multifaceted Human Antigen R (HuR): A Key Player in Liver Metabolism and MASLD.多面手人类抗原R(HuR):肝脏代谢和代谢相关脂肪性肝病中的关键角色
Livers. 2025 Sep;5(3). doi: 10.3390/livers5030033. Epub 2025 Jul 21.
2
Unravelling the therapeutic potential of forkhead box proteins in breast cancer: An update (Review).揭示叉头框蛋白在乳腺癌治疗中的潜力:最新进展(综述)。
Oncol Rep. 2024 Jul;52(1). doi: 10.3892/or.2024.8751. Epub 2024 Jun 7.
3
Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies.

本文引用的文献

1
Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control study.细胞周期蛋白E1是淋巴结阴性乳腺癌死亡的有力预后标志物。一项基于人群的病例对照研究。
Acta Oncol. 2015 Apr;54(4):538-44. doi: 10.3109/0284186X.2014.965274. Epub 2014 Oct 18.
2
Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins.泛癌基因分析确定PARK2为G1/S细胞周期蛋白的主要调节因子。
Nat Genet. 2014 Jun;46(6):588-94. doi: 10.1038/ng.2981. Epub 2014 May 4.
3
Finding the target sites of RNA-binding proteins.
绘制微小RNA的功能,其作为乳腺癌中肿瘤-免疫细胞通讯的关键调节因子及潜在治疗策略。
Front Cell Dev Biol. 2024 Apr 25;12:1390704. doi: 10.3389/fcell.2024.1390704. eCollection 2024.
4
The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects.RNA结合蛋白在乳腺癌中的功能、调控机制及其未来临床治疗前景。
Front Oncol. 2022 Aug 16;12:929037. doi: 10.3389/fonc.2022.929037. eCollection 2022.
5
MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes.微小RNA、Tristetraprolin家族成员与HuR:控制癌症相关进程的复杂相互作用
Cancers (Basel). 2022 Jul 20;14(14):3516. doi: 10.3390/cancers14143516.
6
Hu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors.Hu抗原R(HuR)蛋白在肝胆肿瘤中的结构、功能及调控
Cancers (Basel). 2022 May 27;14(11):2666. doi: 10.3390/cancers14112666.
7
NPSR1-AS1 activates the MAPK pathway to facilitate thyroid cancer cell malignant behaviors via recruiting ELAVL1 to stabilize NPSR1 mRNA.NPSR1-AS1 通过招募 ELAVL1 稳定 NPSR1 mRNA 来激活 MAPK 通路,促进甲状腺癌细胞的恶性行为。
Cell Cycle. 2022 Mar;21(5):439-449. doi: 10.1080/15384101.2021.1979773. Epub 2022 Jan 14.
8
Regulatory Effect of miR497-5p- Axis in Triple-Negative Breast Cancer Cells and Its Predictive Value for Early Diagnosis.miR497-5p轴在三阴性乳腺癌细胞中的调控作用及其早期诊断的预测价值
Cancer Manag Res. 2021 Jan 18;13:439-447. doi: 10.2147/CMAR.S284277. eCollection 2021.
9
GPER1 and microRNA: Two Players in Breast Cancer Progression.GPER1 和 microRNA:乳腺癌进展中的两个参与者。
Int J Mol Sci. 2020 Dec 24;22(1):98. doi: 10.3390/ijms22010098.
10
Regulation of Fetal Genes by Transitions among RNA-Binding Proteins during Liver Development.RNA 结合蛋白在肝发育过程中的转变对胎儿基因的调控。
Int J Mol Sci. 2020 Dec 7;21(23):9319. doi: 10.3390/ijms21239319.
寻找 RNA 结合蛋白的靶位。
Wiley Interdiscip Rev RNA. 2014 Jan-Feb;5(1):111-30. doi: 10.1002/wrna.1201. Epub 2013 Nov 11.
4
Predictive and prognostic significance of cytoplasmic expression of ELAV-like protein HuR in invasive breast cancer treated with neoadjuvant chemotherapy.新辅助化疗治疗浸润性乳腺癌中 ELAV 样蛋白 HuR 的细胞质表达的预测和预后意义。
Breast Cancer Res Treat. 2013 Sep;141(2):213-24. doi: 10.1007/s10549-013-2679-7. Epub 2013 Sep 14.
5
Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer.细胞质HuR表达与乳腺癌中的P-糖蛋白、HER-2阳性及不良预后相关。
Tumour Biol. 2013 Aug;34(4):2299-308. doi: 10.1007/s13277-013-0774-3. Epub 2013 Apr 19.
6
Method for the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts using RIP-Chip.使用RIP-Chip从细胞提取物中分离和鉴定核糖核蛋白复合物的mRNA、微小RNA和蛋白质成分的方法。
J Vis Exp. 2012 Sep 29(67):3851. doi: 10.3791/3851.
7
Functional interplay between RNA-binding protein HuR and microRNAs.RNA 结合蛋白 HuR 与 microRNAs 之间的功能相互作用。
Curr Protein Pept Sci. 2012 Jun;13(4):372-9. doi: 10.2174/138920312801619394.
8
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.孕激素介导的致癌信号下调肿瘤抑制 miR-16 促进乳腺癌发生。
Breast Cancer Res. 2012 May 14;14(3):R77. doi: 10.1186/bcr3187.
9
The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.mRNA 稳定性因子 HuR 抑制 COX-2 的 microRNA-16 靶向作用。
Mol Cancer Res. 2012 Jan;10(1):167-80. doi: 10.1158/1541-7786.MCR-11-0337. Epub 2011 Nov 2.
10
The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.RNA 结合蛋白 HuR 拮抗 microRNA miR-331-3p 对前列腺癌细胞中 ERBB-2 基因表达的抑制作用。
J Biol Chem. 2011 Dec 2;286(48):41442-41454. doi: 10.1074/jbc.M111.301481. Epub 2011 Oct 4.